CD4 and renal cell carcinoma: Extending these findings, our results revealed a notable positive relationship between the apCAFs gene signature and the CD4+ effector T cells gene signature across HNSCC, OV, NPC, CC, CRC, BRCA, CM, and RCC and apCAFs displayed increased expression levels of complement C1Q molecules.